THE COST-EFFECTIVENESS OF ROFLUMILAST IN THE MANAGEMENT OF SEVERE COPD IN THE UK SETTING

被引：0
|
作者：
Kotchie, R. [1 ]
Samyshkin, Y. [1 ]
Zammit, D. C. [2 ]
Humphreys, S. [3 ]
Jameson, K. [3 ]
机构：
[1] IMS Hlth, London, England
[2] IMS Hlth, Basel, Switzerland
[3] MSD Ltd, Hoddesdon, England
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.779
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A140 / A140
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of Roflumilast in the UK: A 1-year study in patients with severe to very severe COPD
    Van Nooten, F.
    Rutten-Van Molken, M.
    Lindemann, M.
    Sandtmann, R.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A260 - A261
  • [2] THE COST-EFFECTIVENESS OF ROFLUMILAST FOR COPD IN SWEDEN
    Engstrom, A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A494 - A494
  • [3] FULLY INCREMENTAL COST-EFFECTIVENESS ANALYSIS OF AVAILABLE TREATMENT OPTIONS IN THE MANAGEMENT OF SEVERE COPD IN THE UK SETTING
    Kotchie, R.
    Samyshkin, Y.
    Hertel, N.
    Radford, M.
    Jameson, K.
    Humphreys, S.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A495 - A495
  • [4] Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
    Samyshkin, Yevgeniy
    Schlunegger, Michael
    Haefliger, Susan
    Ledderhose, Sabine
    Radford, Matthew
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 79 - 87
  • [5] COST-EFFECTIVENESS OF ROFLUMILAST IN COMBINATION WITH BRONCHODILATOR THERAPIES IN PATIENTS WITH SEVERE AND VERY SEVERE COPD IN SWITZERLAND
    Samyshkin, Y.
    Radford, M.
    Schlunegger, M.
    Gooss, A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A494 - A494
  • [6] The cost-effectiveness of physical activity in the management of COPD patients in the UK
    Ramos, Mafalda
    Lamotte, Mark
    Gerlier, Laetitia
    Svangren, Per
    Cases, Anna Miquel
    Haughney, John
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [7] Cost-effectiveness of physical activity in the management of COPD patients in the UK
    Ramos, Mafalda
    Lamotte, Mark
    Gerlier, Laetitia
    Svangren, Per
    Miquel-Cases, Anna
    Haughney, John
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 227 - 239
  • [8] Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany
    Nowak, D.
    Ehlken, B.
    Kotchie, R.
    Wecht, S.
    Magnussen, H.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (04) : 119 - 125
  • [9] Roflumilast as add-on therapy to conventional inhalers in COPD: a cost-effectiveness analysis
    Antoniu, Sabina A.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (04) : 315 - 317
  • [10] Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
    Kiff, Chris
    Ruiz, Sandrine
    Varol, Nebibe
    Gibson, Danny
    Davies, Andrew
    Purkayastha, Debasree
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2707 - 2719
12345